The use of injectable transponders in cattle for identification purposes, for up to 30 months, was investigated. Passive electronic transponders, encapsulated in either polymer or glass, were injected subcutaneously into either the ear base or the earlobe of 652 calves in three populations. The animals were clinically examined weekly, and transponder signalling was checked immediately before and after injection, after two weeks and after about eight months. About 10 per cent of animals in one population were also checked after 20 and 30 months. No severe clinical or visible pathological changes were observed, and the calves' welfare was not apparently affected by the procedure. None of the transponders migrated from their injection sites. Eight months after injection, a signal was detected from 98.2 per cent of transponders injected in the ear base and from 90.5 per cent of those in the earlobe. At 20 and 30 months after injection, 10.4 per cent and 2.6 per cent of transponders, respectively, had ceased to signal. Thus, most transponders in the calves' ear base demonstrated functionality for up to 30 months.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/vr.d2789 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A CT Radiologic Assessment of the Incidence of Cochlear-Facial Dehiscence and the Thickness of Bone between the Cochlea and Facial Nerve among Normal Temporal Bones.
J Neurol Surg B Skull Base
February 2025
Department of Head and Neck Surgery, David Geffen School of Medicine, University of California, Los Angeles, California, CA 90095, United States.
Cochlear-facial dehiscence (CFD) is a relatively new diagnosis which occurs when the bony partition between the labyrinthine segment of the facial nerve and the cochlea is dehiscent. This is considered one of several third window lesions which produce varying degrees of auditory and vestibular symptoms. Imaging studies have identified a consistently higher incidence of CFD when compared with the only histopathologic study present in the literature.
View Article and Find Full Text PDFSystematic empirical evaluation of individual base editing targets: validating therapeutic targets in USH2A and comparison of methods.
Mol Ther
January 2025
Ocular Genomics Institute, Berman-Gund Laboratory for the Study of Retinal Degenerations, Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, 02114, USA. Electronic address:
Base editing shows promise for the correction of human mutations at a higher efficiency than other repair methods and is especially attractive for mutations in large genes that are not amenable to gene augmentation therapy. Here, we demonstrate a comprehensive workflow for in vitro screening of potential therapeutic base editing targets for the USH2A gene and empirically validate the efficiency of adenine and cytosine base editor/guide combinations for correcting 35 USH2A mutations. Editing efficiency and bystander edits are compared between different target templates (plasmids versus transgenes) and assays (Next generation sequencing versus Sanger), as well as comparisons between unbiased empirical results and computational predictions.
View Article and Find Full Text PDFEvaluation of Five Ready-to-Use Bases for the Topical Administration of Propranolol Hydrochloride to Treat Infantile Hemangioma.
Pharmaceutics
January 2025
Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.
: Since 2008, following clinical studies conducted on children that revealed the ability of the β-adrenergic antagonist propranolol to inhibit capillary growth in infantile hemangiomas (IHs), its oral administration has become the first-line treatment for IHs. Although oral propranolol therapy at a dosage of 3 mg/kg/die is effective, it can cause systemic adverse reactions. This therapy is not necessarily applicable to all patients.
View Article and Find Full Text PDFSkull Base Metastasis of Uterine Carcinosarcoma Mimicking Primary Carcinoma of the Middle Ear.
Clin Nucl Med
January 2025
From the Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Uterine carcinosarcoma is a rare type of endometrial carcinoma with poor prognosis. A bone metastasis to the skull base is extremely scarce in uterine carcinosarcoma. A 54-year-old woman with uterine carcinosarcoma complained of right ear otorrhea and otalgia.
View Article and Find Full Text PDFPyrimidinergic P2Y1-Like Nucleotide Receptors Are Functional in Rat Conjunctival Goblet Cells.
Invest Ophthalmol Vis Sci
January 2025
Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States.
Purpose: To investigate the presence of uridine-5'-triphosphate (UTP)-activated P2Y1-like nucleotide receptors (P2Y2R, P2Y4R, and P2Y6R) in conjunctival goblet cells (CGCs) and determine if they increase intracellular Ca2+ concentration ([Ca2+]i) and induce mucin secretion.
Methods: Adult, male rat conjunctiva was used for culture of CGCs. To investigate the expression of P2YRs, mRNA was extracted from CGCs and used for reverse transcription PCR (RT-PCR) with commercially obtained primers specific to P2Y2R, P2Y4R, and P2Y6R.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!